Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831883 · ClinicalTrials.gov registry record · NA
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT00831883: Completed NA study, sponsored by Women and Infants Hospital of Rhode Island.
NCT00831883 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00831883, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.
Interventions
- BEHAVIORAL Healthy Lifestyle
- BEHAVIORAL Partner-Specific IMB-based HIV risk reduction intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT00831883 record still lists
NCT00831883 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Healthy Lifestyle is the first listed.
NCT00831883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00831883 about?
NCT00831883 is a clinical study titled "Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents". The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.
What is the current status of trial NCT00831883?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2009-02. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00831883?
The interventions under investigation include: Healthy Lifestyle (BEHAVIORAL), Partner-Specific IMB-based HIV risk reduction intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00831883?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00831883's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia